Propranolol concentrations in the blood have been measured after oral and i.v. administration of several doses to 6 subjects. After oral administration of doses less than 30 mg, only trace amounts of the drugs were detected in the systemic circulation. With oral doses exceeding 40 mg, the area under the blood concentration/time curve was linearly related to dose. These data suggest that at the low portal venous concentrations occurring after i.v. administration or following small oral doses, the hepatic extraction of propranolol is essentially complete. With the increasing portal venous concentrations that follow oral doses greater than about 30 mg, extraction falls to about 72% and, thereafter, was independent of the dose over the range examined. These findings illustrate a novel form of dose dependent kinetics of elimination which, in subjects receiving doses giving fully effective blood levels, results in a difference in propranolol disposition according to the route of administration. In addition, the presence of the apparent threshold for orally administered drug and the fact that propranolol probably reduces liver blood flow result in a lower estimate of the bioavailability of the drug than that obtained previously.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.